Talk to a public procurement expert
company logo

Licitaciones a Incyte Biosciences Iberia, S.L

Detailed analysis of Incyte Biosciences Iberia, S.L as an awardee: Over the last 6 months it has participated in 103 public procurement procedures, with a success rate of 100%. The average budget of won tenders amounts to 60.648,93 €, with an average discount of 0.00%. The total volume awarded reaches 4.608.165,24 €, distributed among 18 contracting entities. Its main sector is Equipamiento y artículos médicos, farmacéuticos y de higiene personal, representing 69% of its awards. The entity that has awarded it the most contracts is SERVICIO ANDALUZ DE SALUD, with 59 awards.

Tenders

103
Awarded: 103
In progress: 0
Unawarded: 0

Budgets

4.488.021 €
Awarded amount: 4.488.021 €
Minor contracts: 408.350 €
Estimated value: 6.952.621 €

Averages

60.649 €
Discount rate: 0%
Number of bidders: 1,0
Number of lots: 0

Organizations

18
Successful bidders: 1
Minor contracts: 93

Top 5 Contracting organizations

LogoSERVICIO ANDALUZ DE SALUD59
LogoConsejería de Sanidad··>Servicio Madrileño de Salud··>Dirección General Asistencial··>Gerencia Asistencial de Hospitales··>Hospital Universitario Príncipe de Asturias8
LogoConsejería de Sanidad··>Servicio Madrileño de Salud··>Dirección General Asistencial··>Gerencia Asistencial de Hospitales··>Hospital General Universitario Gregorio Marañón6
LogoInstitut Català de la Salut (ICS)5
LogoConsejería de Sanidad··>Servicio Madrileño de Salud··>Dirección General Asistencial··>Gerencia Asistencial de Hospitales··>Hospital Universitario La Paz5

Top 5 Bidders

LogoIncyte Biosciences Iberia, S.L103

Top 5 CPVs

🩺Equipamiento y artículos médicos, farmacéuticos y de higiene personal69
💊Productos farmacéuticos67
💊Medicamentos diversos2
💊Medicamentos usados en dermatología y para el sistema muscular-esquelético1
💉Medicamentos usados en dermatología1

Top 5 Budgets

CONTRACT OBJECTBASE BUDGETDETAILS

Suministro de Ponatinib (DOE)...

1.278.720 € View more

Suministro de Ponatinib (DOE)...

1.278.720 € View more

Suministro de Ruxolitinib fosfato (DOE) crema...

1.132.200 € View more

Suministro del medicamento cuyo Principio Activo es PONATINIB para el Complejo A...

181.152 € View more

P.N.S.P. 20/2025. Suministro del medicamento exclusivo: Ruxolitinib (OPZELURA)...

112.387,5 € View more

Latest tenders won by Incyte Biosciences Iberia, S.L - Diciembre 2025

Be the first to know about all tenders to Incyte Biosciences Iberia, S.L in the last 12 months.

CONTRACT OBJECTBASE BUDGETFILE NUMBERDETAILS

PONATINIB 30MG, COMPRIMIDOS

⏱️ Offer submission deadline: 9 dic 14:45

5328 € CONTR20250000478505View more

TAFASITAMAB 200MG/INYECTABLE IV

⏱️ Offer submission deadline: 5 dic 01:51

8680 € CONTR20250000600733View more

TAFASITAMAB 200MG/INYECTABLE IV

⏱️ Offer submission deadline: 5 dic 00:26

6510 € CONTR20250000582547View more

TAFASITAMAB 200MG/INYECTABLE IV

⏱️ Offer submission deadline: 5 dic 00:03

6510 € CONTR20250000582589View more

TAFASITAMAB 200MG/INYECTABLE IV

⏱️ Offer submission deadline: 4 dic 22:59

8680 € CONTR20250000577990View more

Other Bidders

Explore More Related Content

🏛️

Contracting Organizations

Discover the public organizations this company has worked with and their main contracts.

View organizations
📍

Tenders by Location

Explore the tenders available in Spain where this company could participate.

View tenders in Spain
🏢

Specialization Sectors

Learn about the sectors where this company has more experience and success in tenders.

Explore sectors
📋

Frequent CPV Codes

Review the most used CPV codes in the tenders this company has won.

View CPV codes
⚔️

Direct Competition

Analyze other bidding companies in the same sector to understand the competitive landscape.

View competition
📈

Market Trends

Stay up to date with the latest trends in public procurement and emerging opportunities.

View trends